Evidence map›Paper›PMID 24024142›Full record

ArticleRedox biology2013

Attenuation of lipopolysaccharide (LPS)-induced cytotoxicity by tocopherols and tocotrienols.

Keiko Nishio, Masanori Horie, Yoko Akazawa, Mototada Shichiri, Hitoshi Iwahashi, Yoshihisa Hagihara, Yasukazu Yoshida, Etsuo Niki

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Role of Vitamins in the Pathogenesis of Asthma.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Fruits ofFrontiers in pharmacology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Deficiency of the novel high mobility group protein HMGXB4 protects against systemic inflammation-induced endotoxemia in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Keiko NishioHealth Research Institute, National Institute of Advanced Industrial Science & Technology (AIST), Ikeda 563-8577, Japan.
Masanori Horie
Yoko Akazawa
Mototada Shichiri
Hitoshi Iwahashi
Yoshihisa Hagihara
Yasukazu Yoshida
Etsuo Niki
National Institute of Advanced Industrial Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharide (LPS) induces host inflammatory responses and tissue injury and has been implicated in the pathogenesis of various age-related diseases such as acute respiratory distress syndrome, vascular diseases, and periodontal disease. Antioxidants, particularly vitamin E, have been shown to suppress oxidative stress induced by LPS, but the previous studies with different vitamin E isoforms gave inconsistent results. In the present study, the protective effects of α- and γ-tocopherols and α- and γ-tocotrienols on the oxidative stress induced by LPS against human lung carcinoma A549 cells were studied. They suppressed intracellular reactive oxygen formation, lipid peroxidation, induction of inflammatory mediator cytokines, and cell death. Tocopherols were incorporated into cultured cells much slower than tocotrienols but could suppress LPS-induced oxidative stress at much lower intracellular concentration than tocotrienols. Considering the bioavailability, it was concluded that α-tocopherol may exhibit the highest protective capacity among the vitamin E isoforms against LPS-induced oxidative stress.

Indexed as

AntioxidantsCell DeathCell Line, TumorCytokinesHumansInflammationLipid PeroxidationLipopolysaccharidesLungOxidative StressTocopherolsTocotrienolsAntioxidantsCytokinesLipopolysaccharidesTocopherolsTocotrienolsDCFH, DichlorofluoresceinDPPP, Diphenyl-1-pyrenylphosphineLipid peroxidationLipopolysaccharide (LPS)LPS, LipopolysaccharideMTT, 3-[4,5-dimethylthiazol-2-yl]2,5-dipheyltetrazolium bromideNF-κB, Nuclear factor-kappaBOxidative stressROS, Reactive oxygen speciesSP-D, Pulmonary surfactant protein DTNF-α, Tumor necrosis factor αToc3, TocotrienolTocopherolTocotrienolToc, TocopherolVitamin E

Identifiers

PMID24024142
PMCPMC3757666
OpenAlexW2049738744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.